ESR1 and triple-negative breast carcinoma: Triple negative breast cancer (TNBC), defined by a lack of tumor-cell expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for approximately 15-20% of all BCs (1).